Your browser is no longer supported. Please, upgrade your browser.
We’ve redesigned our maps and bubbles! Read more about the new features here. ×
Settings
ENDP [NASD]
Endo International plc
IndexS&P 500 P/E- EPS (ttm)-11.05 Insider Own0.50% Shs Outstand172.71M Perf Week0.29%
Market Cap14.72B Forward P/E18.07 EPS next Y4.72 Insider Trans0.00% Shs Float169.13M Perf Month6.91%
Income-1296.20M PEG- EPS next Q1.11 Inst Own98.80% Short Float13.12% Perf Quarter17.57%
Sales2.50B P/S5.88 EPS this Y21.20% Inst Trans9.54% Short Ratio8.58 Perf Half Y30.68%
Book/sh16.25 P/B5.25 EPS next Y11.78% ROA-15.80% Target Price83.61 Perf Year7.45%
Cash/sh4.13 P/C20.62 EPS next 5Y7.68% ROE-65.70% 52W Range53.62 - 87.36 Perf YTD18.19%
Dividend- P/FCF91.95 EPS past 5Y-33.80% ROI-8.50% 52W High-2.43% Beta1.13
Dividend %- Quick Ratio1.10 Sales past 5Y15.70% Gross Margin54.70% 52W Low58.97% ATR2.15
Employees3371 Current Ratio1.30 Sales Q/Q15.50% Oper. Margin19.40% RSI (14)66.20 Volatility2.78% 2.68%
OptionableYes Debt/Eq1.76 EPS Q/Q-456.50% Profit Margin-57.60% Rel Volume0.49 Prev Close85.19
ShortableYes LT Debt/Eq1.69 EarningsMar 02 BMO Payout- Avg Volume2.59M Price85.24
Recom2.00 SMA203.63% SMA509.42% SMA20021.55% Volume1,262,984 Change0.06%
Feb-02-15Reiterated CRT Capital Fair Value $73 → $80
Jan-30-15Reiterated Deutsche Bank Buy $81 → $91
Sep-02-14Initiated RBC Capital Mkts Outperform $80
Aug-01-14Reiterated Stifel Buy $75 → $84
Jun-27-14Initiated Canaccord Genuity Buy $83
Apr-30-14Initiated National Alliance Securities Buy $76
Mar-04-14Reiterated FBR Capital Mkt Perform $52 → $82
Mar-03-14Reiterated UBS Buy $75 → $90
Nov-06-13Upgrade Needham Underperform → Hold
Nov-06-13Reiterated Stifel Buy $40 → $60
Oct-30-13Initiated FBR Capital Mkt Perform $40
Sep-20-13Reiterated UBS Buy $43 → $50
Jun-21-13Resumed Oppenheimer Perform
Jun-06-13Reiterated UBS Buy $39 → $41
Jun-06-13Reiterated Stifel Buy $36 → $40
Jun-06-13Downgrade Cantor Fitzgerald Hold → Sell $36 → $30
May-13-13Reiterated Stifel Buy $42 → $36
May-08-13Reiterated RBC Capital Mkts Underperform $28 → $29
Apr-17-13Reiterated Stifel Buy $38 → $42
Apr-10-13Downgrade Standpoint Research Buy → Hold
Feb-26-15 10:50AM  What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Zacks
Feb-25-15 03:46PM  Comcast Corporation (CMCSA), Yahoo! Inc. (YHOO): Among Largest New Bets of Billionaire Daniel Och at Insider Monkey
01:05PM  Soros increases its position in United Continental Holdings Market Realist
10:30AM  Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog Zacks
Feb-24-15 05:06PM  Priceline Group loses its position in Chilton Investment Company Market Realist
03:05PM  Soros continues to be bullish on Dow Chemical Market Realist
12:53PM  Oclaro, Inc. (OCLR): Soros Fund Managements Latest Acquisition and Other New Positions at Insider Monkey
Feb-23-15 02:30PM  How Raleigh's BioDelivery will use $10M it got from partner on pain drug at American City Business Journals
01:19PM  Hedgies all-in on stocks; here's how to play it at CNBC
01:05PM  Soros opens a new position in Allergan Market Realist
12:50PM  Salix break-up fee signals it's serious about playing ball with Valeant at American City Business Journals
11:28AM  Salix Pharmaceuticals: Will Another Buyer Push Valeant's Bid Higher? at Barrons.com
09:05AM  Soros opens new position in LendingClub Market Realist
09:00AM  BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in Conjunction with Acceptance of NDA for BELBUCA (buprenorphine HCl) Buccal Film for Chronic Pain PR Newswire
07:30AM  Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA (buprenorphine HCl) Buccal Film for the Management of Chronic Pain PR Newswire
07:30AM  Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA (buprenorphine HCl) Buccal Film for the Management of Chronic Pain CNW Group
Feb-20-15 03:06PM  Soros Fund Management adds a new position in Endo International Market Realist
01:05PM  Endo International is one of Chilton Investments new positions Market Realist
11:10AM  Ecolab's (ECL) Q4 Earnings: Will it Disappoint Estimates? - Analyst Blog Zacks
11:06AM  LyondellBasell is a brand new position in Soros 4Q portfolio Market Realist
Feb-19-15 04:30PM  American Medical Systems Announces 1,000th Patient Enrolled in PROPPER Registry PR Newswire
04:30PM  American Medical Systems Announces 1,000th Patient Enrolled in PROPPER Registry CNW Group
08:45AM  Top Analyst Upgrades and Downgrades: Coach, Garmin, Intelsat, Potbelly, SolarCity, Valero and More at 24/7 Wall St.
Feb-18-15 04:21PM  George Soros Sells Apple and Intel, Sticks With Alibaba at TheStreet
10:35AM  Will Patterson Companies (PDCO) Earnings Disappoint in Q4? - Analyst Blog Zacks
Feb-17-15 02:40PM  Will Community Health Systems (CYH) Q4 Earnings Miss? - Analyst Blog Zacks
Feb-13-15 09:00AM  Endo to Announce Fourth Quarter 2014 Financial Results on March 2, 2015 PR Newswire
09:00AM  Endo to Announce Fourth Quarter 2014 Financial Results on March 2, 2015 CNW Group
Feb-11-15 12:18PM  Endo Finance Co. -- Moody's upgrades Endo's sr. secured debt to Baa3; CFR unaffected at Moody's
Feb-09-15 05:02PM  Paladin Labs Announces the Canadian Launch of Zincofax® Spray CNW Group
Feb-06-15 08:52AM  Can Endo International (ENDP) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape Zacks
Feb-05-15 03:31PM  BioSpecifics Announces Label Expansion for Xiaflex in EU - Analyst Blog Zacks
Feb-03-15 08:30AM  American Medical Systems (AMS) sponsors Healthy Body Healthy Mind episode to raise awareness of Stress Urinary Incontinence and treatment options PR Newswire
08:30AM  American Medical Systems (AMS) sponsors Healthy Body Healthy Mind episode to raise awareness of Stress Urinary Incontinence and treatment options CNW Group
Feb-02-15 04:30PM  Paladin Labs Announces the Canadian Launch of Dynamiclear Rapid CNW Group
11:52AM  5 Rocket Stocks to Buy for February Gains: Apple, Mallinckrodt and More at TheStreet
Jan-30-15 04:55PM  ENDO INTERNATIONAL PLC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
Jan-29-15 04:51PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or D EDGAR Online
04:30PM  Endo Completes Acquisition Of Auxilium Pharmaceuticals PR Newswire
04:30PM  Endo Completes Acquisition Of Auxilium Pharmaceuticals CNW Group
Jan-27-15 05:38PM  NPS Pharmaceuticals' Natpara Approved with Boxed Warning - Analyst Blog Zacks
05:26PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial EDGAR Online
Jan-23-15 07:00AM  Endo International plc (ENDP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-22-15 05:10PM  Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog Zacks
11:10AM  Big payday looming for Auxilium executives at American City Business Journals
Jan-21-15 05:58PM  Endo International Set to Join the S&P 500; Boston Beer to Join S&P MidCap 400; Southside Bancshares to Join S&P SmallCap 600 PR Newswire
05:31PM  Endo International Tapped to Join S&P 500 at Barrons.com
02:00PM  ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog Zacks
09:30AM  Zacks.com featured expert Kevin Matras highlights: Endo International, Vulcan Materials, Ambarella, Jones Lang LaSalle and Skullcandy - Press Releases Zacks
08:17AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Endo International plc Announces Pricing of Private Offering Of Senior Notes PR Newswire
08:00AM  Endo International plc Announces Pricing of Private Offering Of Senior Notes CNW Group
Jan-20-15 06:12PM  Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog Zacks
03:15PM  Endo Limited -- Moody's rates Endo's new senior notes B1; stable outlook at Moody's
02:10PM  Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog Zacks
08:45AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
08:30AM  Endo International plc Announces Proposed Private Offering Of Senior Notes PR Newswire
08:30AM  Endo International plc Announces Proposed Private Offering Of Senior Notes CNW Group
01:00AM  Get Ready To Be Surprised This Earnings Season - Screen of the Week Zacks
Jan-19-15 04:10PM  OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog Zacks
02:10PM  UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog Zacks
Jan-15-15 05:17PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi EDGAR Online
02:42PM  Endo Finance LLC -- Moody's confirms Endo at Ba3; stable outlook at Moody's
02:00PM  BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst Blog Zacks
Jan-14-15 06:05PM  ARIAD Reveals 2015 Strategic Objectives, Updates on Pipeline - Analyst Blog Zacks
Jan-09-15 10:27AM  Endo changing its management structure at American City Business Journals
08:00AM  Endo Announces Changes to Senior Management Team PR Newswire
08:00AM  Endo Announces Changes to Senior Management Team CNW Group
Jan-08-15 04:20PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi EDGAR Online
Jan-05-15 04:30PM  Endo Announces Retirement of Chief Legal Officer PR Newswire
04:30PM  Endo Announces Retirement of Chief Legal Officer CNW Group
Jan-01-15 10:20AM  Glenview Capital raises position in Endo International Market Realist
Dec-26-14 06:20PM  Stock Market Video Analysis for Week Ending 12/26/14 Yahoo Finance Blogs
Dec-24-14 05:10PM  For this drug developer, 2014 was 'best year in company history' at bizjournals.com
12:35PM  New chronic pain treatment could soon be available thanks to Raleigh drug developer at bizjournals.com
Dec-23-14 03:42PM  Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain PR Newswire
03:42PM  Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain CNW Group
Dec-22-14 04:01PM  Endo Announces Appearances at Upcoming Conferences PR Newswire
04:01PM  Endo Announces Appearances at Upcoming Conferences CNW Group
Dec-12-14 12:01AM  Bard Judge Says Implant Maker Facing Billions in Verdicts at Bloomberg
Dec-11-14 05:00PM  Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC PR Newswire
05:00PM  Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC CNW Group
Dec-09-14 07:00AM  Endo Completes Acquisition of Rights to Natesto Testosterone Nasal Gel PR Newswire
07:00AM  Endo Completes Acquisition of Rights to Natesto Testosterone Nasal Gel CNW Group
Dec-03-14 02:06PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
Nov-24-14 07:00AM  Endo Acquires Rights to Natesto Testosterone Nasal Gel PR Newswire
07:00AM  Endo Acquires Rights to Natesto Testosterone Nasal Gel CNW Group
Nov-20-14 09:57AM  U.S. court denies Ranbaxy's bid to block launch of rival generics Reuters
07:30AM  Endo Announces Launch of Generic Version of Valcyte® PR Newswire
07:30AM  Endo Announces Launch of Generic Version of Valcyte® CNW Group
Nov-19-14 07:30AM  Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals PR Newswire
Nov-18-14 01:04PM  ENDO INTERNATIONAL PLC Financials EDGAR Online Financials
10:01AM  Endo International (ENDP) Strong On High Relative Volume Today at TheStreet
Nov-10-14 05:10PM  ENDO INTERNATIONAL PLC Files SEC form 10-Q, Quarterly Report EDGAR Online
09:54AM  Dr. Reddy's Laboratories: The Bridge to 2016 at Barrons.com
08:00AM  Endo Receives Final Approval for Generic Version of Valcyte® PR Newswire
05:38AM  La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% Zacks
Nov-07-14 05:44AM  Dr Reddy's gets FDA approval for Roche drug generic; shares at record high Reuters
Nov-06-14 11:26PM  Dr Reddy's, Endo get FDA approval to launch generic Valcyte Reuters
08:30AM  Endo International Beats on Q3 Earnings & Sales, View Up Zacks
Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men's and women's health, and prostate health. The company's products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.